Cartesian Therapeutics
RNAC
#6732
Rank
โ‚ฌ0.43 B
Marketcap
18,12ย โ‚ฌ
Share price
3.61%
Change (1 day)
-41.06%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -0,30ย โ‚ฌ

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -0,29ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -0,22ย โ‚ฌ an increase over its 2020 EPS that were of -0,63ย โ‚ฌ.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,30ย โ‚ฌ
2021-0,22ย โ‚ฌ-65.22%
2020-0,63ย โ‚ฌ-43.44%
2019-1,12ย โ‚ฌ-58.08%
2018-2,66ย โ‚ฌ-9.35%
2017-2,94ย โ‚ฌ-29.16%
2016-4,15ย โ‚ฌ